Each year we fund up to 10 projects via our LGR Innovation Award program, which provides pilot funds to enable cutting-edge, CRISPR-based innovation within the laboratories of UCSF and UCB faculty. Examples include, but are not limited to: single-cell sequencing applications, improved lentiviral or RNP-based delivery methods, robust genetic or chemical iPSC differential protocols, development of novel dCas9 fusion proteins for use in screens.
An unprecedented type of joint venture where UCSF, UCB & GSK researchers work side-by-side to brainstorm, design & execute projects. From genome-wide CRISPR screens in disease-relevant cell lines to developing novel CRISPR-based toolsets, each project combines the strengths of industry & academia to deepen our understanding of genetics, discover new targets, and create next-generation technologies.
